Recombinant Human PAK2 Protein (Baculovirus)，GST

PAK2 (p21-activated kinase 2) is a crucial member of the p21-activated kinase family, which plays a significant role in various cellular processes, including cell motility, survival, and proliferation. It is a serine/threonine kinase that is activated by small GTPases, such as Cdc42 and Rac1, and is involved in signaling pathways that regulate cytoskeletal dynamics and gene expression. Research on PAK2 has gained momentum due to its implications in various diseases, including cancer and neurodegenerative disorders, where its dysregulation can contribute to tumor progression and metastasis. The study of recombinant PAK2 proteins has become essential for understanding its structure-function relationships, enzymatic activity, and interactions with other cellular components. By producing and analyzing these recombinant proteins, researchers aim to unravel the mechanisms through which PAK2 exerts its biological effects and to identify potential therapeutic targets for interventions in diseases associated with abnormal PAK2 activity. Current investigations focus on its role in promoting cancer cell migration and invasion, as well as its involvement in cytoskeletal reorganization. Furthermore, the development of specific PAK2 inhibitors is of great interest in pharmacological research, as they may offer novel strategies for cancer treatment. Overall, the exploration of PAK2 recombinant proteins not only enhances our understanding of this kinase's fundamental biology but also holds promise for advancing therapeutic options in various pathologies linked to its function.